Bibersteinia trehalosi in Cattle: Sudden Death, Diagnosis and Herd Response

By Dr Duncan Houston

Sudden respiratory deaths in cattle demand fast action, but an unusual bacterial name should not distract from proper outbreak investigation.

Bibersteinia trehalosi has caused documented cases of acute pneumonia, pleuropneumonia, septicaemia and sudden death in cattle. Some outbreaks have progressed so quickly that affected animals were found dead without obvious illness at the previous inspection. (Korea Science)

However, isolation of B. trehalosi does not automatically prove that it initiated the disease. It may act as a primary pathogen in selected cases, a secondary invader following viral respiratory damage, or an opportunistic organism within a more complicated bovine respiratory disease complex.

The key decisions are whether the bacterium was recovered from a meaningful lesion, whether the pathology fits, whether other pathogens are present and whether the herd is experiencing an isolated event or a rapidly escalating emergency.

Quick Answer

Bibersteinia trehalosi can cause severe pneumonia and septicaemia in calves and adult cattle, including peracute cases with sudden death. It remains much less commonly identified than major bovine respiratory bacteria such as Mannheimia haemolytica and Pasteurella multocida.

Multiple sudden deaths, severe respiratory distress, recumbency or rapid treatment failure requires immediate on-farm veterinary investigation. Diagnosis should be based on fresh necropsy material, lower-respiratory or lesion-associated samples, histopathology, species-level bacterial identification and antimicrobial susceptibility testing.

Bibersteinia trehalosi at a Glance

Question	Practical answer
What is it?	A Gram-negative bacterium in the Pasteurellaceae family
Is it new in cattle?	No. Bovine cases have been documented for years
Is it common?	No. It is identified much less frequently than the major BRD bacteria
Can it cause sudden death?	Yes, particularly with severe pneumonia or septicaemia
Is it always a primary pathogen?	No. Some isolates may act as secondary or opportunistic organisms
Can a nasal swab confirm causation?	No. Sample site, lesions and concurrent pathogens matter
Does leukotoxin PCR prove virulence?	No. It detects a potential virulence gene, not clinical causation
Is ceftiofur always the correct treatment?	No. Treatment must reflect susceptibility, drug labels and local food-animal law
Can vaccination help?	Cross-protection was demonstrated with one specific toxoid-containing vaccine in one controlled study
When is it an emergency?	Rapid case accumulation, severe dyspnoea, recumbency or multiple sudden deaths

In one Wisconsin diagnostic-laboratory dataset, B. trehalosi represented 151 of 4,261 bovine respiratory isolates, approximately 4%. This was a selected diagnostic population rather than a measure of prevalence in all cattle, but it illustrates that the organism is uncommon relative to the major BRD bacteria. (PubMed)

What Is Bibersteinia trehalosi?

B. trehalosi is a Gram-negative, non-motile member of the Pasteurellaceae family. It was previously classified within the Pasteurella haemolytica complex and was formally transferred to the newly created genus Bibersteinia in 2007 following genotypic and phenotypic analysis. (PubMed)

The organism is best known for causing systemic pasteurellosis, pneumonia and septicaemia in sheep. It has also been recovered from goats, cattle, bison and wild ruminants.

Like Mannheimia haemolytica, some B. trehalosi strains carry a leukotoxin gene. Leukotoxin may contribute to tissue injury by targeting ruminant leukocytes, but its presence does not mean that every isolate will cause severe disease in cattle. A leukotoxin-positive bovine isolate failed to produce greater lung involvement than control inoculation in one calf challenge study. (SpringerLink)

Is Bibersteinia trehalosi Really Emerging in Cattle?

The term “emerging” should be used carefully.

There are documented bovine outbreaks from North America, Europe, New Zealand and Korea. These reports confirm that B. trehalosi can cause genuine and sometimes devastating cattle disease. They do not establish that the organism is currently causing a worldwide bovine epidemic. (Bovine OJS TAMU)

The strongest recent official surveillance signal is in sheep, not cattle. Great Britain recorded a substantial increase in diagnosed B. trehalosi septicaemia incidents in sheep during 2025, including 64 diagnoses in the fourth quarter compared with 10 during the same quarter in 2020. That report specifically described sheep disease and should not be presented as proof of a parallel cattle trend. (GOV.UK)

Recent cattle evidence continues to show occasional detection rather than dominance. A 2026 Austrian study found B. trehalosi in two of 48 bronchoalveolar lavage samples from calves on farms with a history of bronchopneumonia, while none of the corresponding deep nasopharyngeal samples yielded it. (PubMed)

Based on the currently available evidence, the most accurate description is:

Bibersteinia trehalosi is an uncommon but potentially severe bovine pathogen whose clinical importance depends on the strain, host, sampling site, lesions and concurrent disease.

Is It a Primary Pathogen or an Opportunist?

It may be either, depending on the case.

Evidence That It Can Cause Primary Disease

Field reports have documented dominant or pure growth of B. trehalosi from severe bovine lesions.

Examples include:

• Peracute to acute fatal pneumonia in cattle in North America

• Sudden death with severe pneumonia and septicaemia in two Korean cattle

• Fibrinous pleuropneumonia, polyserositis and septicaemia in neonatal New Zealand calves

• Less common manifestations including necrotising hepatitis and subcutaneous infection

These cases demonstrate that the bacterium can behave as a clinically important invasive pathogen. (Bovine OJS TAMU)

Evidence That It May Be Secondary

In a controlled study involving 36 calves, inoculation with leukotoxin-positive or leukotoxin-negative bovine B. trehalosi isolates did not produce significantly greater lung involvement than negative control inoculation. The organism was recovered from the lungs only once at necropsy. (SpringerLink)

This does not invalidate the fatal field cases. It suggests that:

• Virulence differs between strains.

• Some isolates require prior respiratory damage.

• Viral infection or another bacterium may create the opportunity for invasion.

• Host immunity and environmental conditions influence the outcome.

• Recovery from a diagnostic sample does not always mean primary causation.

In practice, the diagnosis is strongest when B. trehalosi is recovered in dominant or pure growth from active lesions or normally sterile tissues and the pathology supports bacterial pneumonia or septicaemia.

What Makes Cattle Vulnerable?

Bovine respiratory disease is rarely caused by one factor acting alone. Host immunity, respiratory viruses, bacterial populations, transport, ventilation, stocking density and nutrition interact.

Factors that may increase vulnerability include:

• Recent transport or mixing

• Weaning stress

• Overcrowding

• Poor air exchange

• High humidity or ammonia

• Inadequate colostrum intake

• Abrupt nutritional changes

• Viral respiratory infection

• Previous antimicrobial exposure

• Existing pneumonia

• Other systemic disease

Major viral and bacterial BRD organisms commonly considered alongside B. trehalosi include bovine respiratory syncytial virus, bovine herpesvirus 1, bovine viral diarrhoea virus, parainfluenza 3, bovine coronavirus, M. haemolytica, P. multocida, Histophilus somni and Mycoplasma bovis. (SpringerLink)

The New Zealand neonatal outbreak is a useful example. Fifteen of 40 calves less than 48 hours old became acutely ill, and 11 died or were euthanased. Poor hygiene, biosecurity and ventilation were identified in the calf pens, showing that the bacterial result had to be interpreted within the management environment. (PubMed)

What Are the Clinical Signs?

The clinical presentation may be peracute, acute or less dramatically progressive.

Peracute Disease

The first sign may be:

• An animal found dead

• Sudden recumbency

• Inability to rise

• Severe respiratory distress

• Haemorrhagic or frothy material at the mouth or nostrils

• Rapid deterioration over a few hours

Two Korean cattle were reportedly clinically normal on the day before death. Necropsy identified severe pneumonia, septicaemia, widespread haemorrhage and enlarged mediastinal lymph nodes. (Korea Science)

Acute Respiratory Disease

Possible signs include:

• Fever

• Tachypnoea

• Increased abdominal respiratory effort

• Coughing

• Nasal discharge

• Reduced appetite

• Reduced rumination

• Depression

• Separation from the group

• Tachycardia

• Abnormal lung sounds

• Rapid progression despite treatment

A high fever is possible, but it is not required. The affected neonatal calves in the New Zealand outbreak showed tachypnoea, tachycardia, recumbency, weakness and inability to feed without pyrexia. (ResearchGate)

Septicaemia

Systemic spread may cause:

• Profound weakness

• Shock

• Dehydration

• Recumbency

• Polyarthritis

• Swollen joints

• Polyserositis

• Widespread petechial or ecchymotic haemorrhage

• Sudden death

Recovery of the organism from lung, joint and peritoneal material in the New Zealand outbreak supported systemic infection rather than incidental upper-airway carriage. (ResearchGate)

What May Be Found at Necropsy?

Reported lesions include:

• Severe fibrinous or fibrinosuppurative bronchopneumonia

• Pleuropneumonia

• Pulmonary congestion and oedema

• Thickened interlobular septa

• Lungs that remain heavy or incompletely collapsed

• Haemorrhagic froth within the trachea

• Enlarged or haemorrhagic mediastinal lymph nodes

• Petechial and ecchymotic haemorrhages

• Fibrin within the pleural, pericardial or abdominal cavities

• Polyarthritis

• Polyserositis

• Septicaemic lesions in several organs

These lesions are not specific to B. trehalosi. The diagnosis requires laboratory confirmation and investigation for other BRD agents. (Korea Science)

How Worried Should You Be?

Lower Immediate Concern

The situation involves:

• One mild respiratory case

• No deaths

• Stable appetite and rumination

• A positive upper-respiratory sample only

• A satisfactory response to the existing BRD protocol

• No unusual necropsy lesions

Action: Review the result with the herd veterinarian, but do not rebuild the entire antimicrobial programme around one nasal isolate.

Moderate Concern

The group has:

• One unexplained sudden death

• Several new febrile or tachypnoeic animals

• Increasing treatment failure

• A recent high-risk event such as transport or mixing

• B. trehalosi reported from a respiratory sample

Action: Arrange prompt herd examination and obtain stronger diagnostic samples. A fresh necropsy may be more informative than additional superficial swabs.

High Concern

The herd has:

• Several deaths over 12 to 48 hours

• Severe pneumonia at necropsy

• Rapidly increasing case numbers

• Recumbent animals

• Failure of first-line treatment

• Evidence of septicaemia or polyarthritis

• Dominant or pure B. trehalosi growth from active lesions

Action: Treat this as an active herd outbreak. Begin a veterinarian-directed investigation and control programme immediately.

Critical

Cattle are:

• Open-mouth breathing

• Unable to rise

• Collapsing

• Producing haemorrhagic froth

• Dying before treatment can be administered

• Showing a sharp mortality increase over several hours

Action: Contact the attending livestock veterinarian immediately. Severely affected cattle may require emergency treatment or humane euthanasia, while the freshest suitable carcass should be prioritised for diagnostic examination.

What Else Can Cause Sudden Respiratory Death?

Important rule-outs include:

Differential diagnosis	Why it matters
Mannheimia haemolytica	Can cause acute fibrinous bronchopneumonia and pleuritis
Histophilus somni	May cause pneumonia, septicaemia, myocarditis or neurological disease
Pasteurella multocida	Commonly participates in bacterial bronchopneumonia
Mycoplasma bovis	Causes pneumonia, arthritis, otitis and persistent treatment failure
Bovine respiratory syncytial virus	Can produce severe respiratory distress and predispose to bacterial invasion
Bovine herpesvirus 1	Causes respiratory epithelial injury and secondary bacterial disease
Salmonella Dublin	May cause calf pneumonia, septicaemia and sudden death
Aspiration pneumonia	Consider after drenching, tubing, difficult calving or swallowing dysfunction
Atypical interstitial pneumonia	Important in heavier or late-fed cattle with acute respiratory distress
Acute pulmonary oedema or cardiac disease	May cause froth, dyspnoea and rapid collapse
Clostridial disease	A major differential for sudden death with limited warning
Toxic exposure	Consider when several animals become ill rapidly after a shared exposure

The real concern is not simply whether B. trehalosi was detected. It is whether the organism was recovered from the correct site, with matching lesions, and whether a more convincing diagnosis has been excluded.

When Is This an Emergency?

Immediate on-farm veterinary investigation is required when there is:

• More than one unexplained death over a short period

• Rapidly increasing respiratory morbidity

• Severe dyspnoea

• Recumbency

• Haemorrhagic froth

• Neonatal calves unable to stand or suck

• Evidence of septicaemia

• Animals failing to respond to the existing treatment protocol

• New deaths occurring within hours of the first clinical signs

Do not wait for a culture report before alerting the herd veterinarian when the outbreak is moving quickly. Diagnostic samples can be collected and appropriate empirical treatment started under veterinary direction while results are pending.

What To Do Right Now

1. Contact the Attending Herd Veterinarian

Provide:

• Number at risk

• Number clinically affected

• Number dead

• Age and production class

• Pen, paddock or management group

• Speed of progression

• Temperatures

• Respiratory rates and effort

• Treatments already given

• Dates of transport, weaning, mixing and vaccination

• Recent antimicrobial exposure

• Ventilation and stocking changes

• Any concurrent sheep or goat disease

2. Examine the Entire Epidemiological Group

Check more than the most obvious cases.

Record:

• Rectal temperature

• Respiratory rate

• Respiratory effort

• Appetite

• Rumination

• Coughing

• Nasal discharge

• Depression

• Ability to rise

• Joint swelling

• Hydration

Early cases may still be standing and deceptively responsive.

3. Necropsy the Freshest Suitable Carcass

Ideally select a recently dead, minimally treated animal.

Useful samples may include:

• Fresh lung from the edge of active lesions

• Fixed lung from several affected and unaffected areas

• Tracheobronchial or mediastinal lymph node

• Tracheal material

• Spleen and liver when septicaemia is suspected

• Heart blood from a very fresh carcass

• Pleural or peritoneal fluid

• Joint fluid when polyarthritis is present

• Samples for respiratory virus testing

Avoid contaminating deep tissue with hide, gut contents or the environment during collection.

4. Sample Live Cattle Appropriately

A bronchoalveolar lavage or transtracheal sample is generally more representative of lower respiratory infection than an ordinary nasal swab.

A 2026 study found poor agreement between deep nasopharyngeal and bronchoalveolar culture results for most BRD-associated bacteria. B. trehalosi was recovered from two lower-airway samples but no corresponding nasopharyngeal samples. (PubMed)

5. Investigate Concurrent Pathogens

Request testing appropriate to the herd history and lesions rather than stopping when the first bacterial name appears.

6. Preserve Treatment and Withdrawal Records

Record:

• Animal identification

• Drug

• Dose

• Route

• Date and time

• Person administering treatment

• Clinical response

• Retreatment

• Milk withdrawal

• Meat withdrawal

7. Review the Environment Immediately

Assess:

• Ventilation

• Humidity

• Ammonia

• Bedding moisture

• Stocking density

• Calf-feeding hygiene

• Colostrum management

• Recent mixing

• Shared equipment

• Water access

The laboratory result will not correct the conditions that enabled the outbreak.

How Is Bibersteinia trehalosi Diagnosed?

Bacterial Culture

Culture remains important because it provides a viable isolate for species confirmation and susceptibility testing.

The strongest evidence includes:

• Dominant or pure growth

• Recovery from active lung lesions

• Recovery from normally sterile tissue or fluid

• Similar results from multiple affected cattle

• Matching bacterial pneumonia or septicaemia on histopathology

A superficial nasal isolate without matching lesions is weaker evidence.

MALDI-TOF Mass Spectrometry

MALDI-TOF can provide rapid species-level bacterial identification.

It was used in the Korean cattle cases and the New Zealand neonatal outbreak. Rapid MALDI-TOF methods have also been evaluated for identifying respiratory bacterial pathogens from bronchoalveolar lavage material after short laboratory enrichment. (Korea Science)

Gene Sequencing

16S rRNA and sodA sequencing may help distinguish B. trehalosi from closely related Pasteurellaceae when routine identification is uncertain. The Korean isolates were confirmed using MALDI-TOF together with 16S rRNA and sodA sequence analysis. (Korea Science)

PCR

A real-time PCR targeting the B. trehalosi leukotoxin gene has been developed to detect leukotoxin-producing forms of the organism in mixed Pasteurellaceae samples. (PubMed Central (PMC))

Important limitations include:

• Leukotoxin-negative strains will not be identified by a leukotoxin-targeted assay.

• Gene detection does not confirm bacterial viability.

• Detection does not prove tissue invasion.

• Leukotoxin positivity does not prove that the strain caused the outbreak.

• Histopathology and sample location remain essential.

Histopathology

Histopathology helps determine whether the disease pattern fits:

• Acute bacterial bronchopneumonia

• Fibrinous pleuropneumonia

• Septicaemia

• Viral respiratory injury

• Chronic treated pneumonia

• Interstitial rather than bacterial lung disease

The presence of syncytial cells, inclusion bodies or characteristic viral lesions may indicate that bacterial infection developed after viral damage.

Antimicrobial Susceptibility Testing

Susceptibility testing is particularly important because resistance varies between isolates.

In the Wisconsin dataset, B. trehalosi had the highest median proportion of isolates resistant to at least one antimicrobial among the four bacterial BRD groups studied. A separate bovine isolate had genes associated with resistance to several antimicrobial classes. (PubMed)

No single historical antibiogram should be copied onto another herd.

How Is It Treated?

There is no universal B. trehalosi treatment protocol.

Treatment depends on:

• Severity

• Animal age and production class

• Outbreak speed

• Previous antimicrobial exposure

• Culture and susceptibility results

• Concurrent pathogens

• Drug approval

• Route and practical administration

• Milk and meat withdrawal

• Regional antimicrobial regulation

Antimicrobial Treatment

When cattle are deteriorating rapidly, the veterinarian may collect diagnostic samples and begin empirical treatment before culture results are available.

The protocol should then be reviewed when:

• Species identification is confirmed

• Susceptibility results return

• New deaths occur

• Treated animals fail to respond

• Another pathogen is identified

• The original diagnosis becomes less convincing

The statement that cephalosporins are the only reliably effective class is incorrect. Resistance patterns vary, and susceptibility to several non-cephalosporin classes has been documented in selected isolate populations. Conversely, multidrug-resistant bovine isolates also exist. (PubMed)

Food-Animal Drug Rules Matter

Drug selection cannot be separated from legal use and residues.

In the United States, certain extralabel cephalosporin uses in cattle are prohibited, including unapproved dose, route, frequency or duration changes and use for disease prevention. Treatment or control of an extralabel disease indication may be permitted only under defined conditions while adhering to an approved cattle dosage regimen. (U.S. Food and Drug Administration)

FDA also warned a manufacturer in 2026 that marketing a cattle BRD antimicrobial as broadly effective against respiratory disease was misleading when efficacy had only been established for specified labelled pathogens and not B. trehalosi. (U.S. Food and Drug Administration)

Regulations differ by country. The attending veterinarian must confirm:

• Whether the product is authorised for the production class

• Whether the intended disease use is permitted

• Correct dose and route

• Treatment interval

• Milk withdrawal

• Meat withdrawal

• Record-keeping requirements

Supportive Care

Depending on the animal, supportive treatment may include:

• Anti-inflammatory and analgesic medication

• Fluid and electrolyte support

• Oxygen where practical

• Assisted feeding or nursing for weak neonatal calves

• Treatment of shock

• Management of joint infection

• Treatment of concurrent viral or bacterial disease

• Protection from environmental extremes

A profoundly hypoxic or septicaemic animal may not survive on an antimicrobial injection alone.

When Should Group Treatment Be Considered?

Veterinarian-directed group treatment may be considered when:

• One defined group is experiencing rapidly increasing disease

• New cases are difficult to identify before severe deterioration

• Mortality is rising

• The expected benefit justifies antimicrobial exposure

• The proposed use is lawful

• Individual and group withdrawal records can be maintained

This is not the same as automatically giving ceftiofur to every herd in which B. trehalosi is suspected.

When Is Euthanasia Appropriate?

Humane euthanasia should be considered when an animal has:

• Severe unrelenting respiratory distress

• Advanced septicaemic shock

• Inability to rise

• No realistic prospect of treatment response

• Severe suffering that cannot be relieved promptly

Continuing repeated treatment in a moribund animal may prolong distress without changing the outcome.

Does Vaccination Protect Cattle?

One controlled study evaluated a multivalent modified-live viral vaccine containing a specific M. haemolytica toxoid. Vaccinated calves had reduced mortality, lower respiratory scores and lower lung-lesion scores following challenge with a virulent B. trehalosi isolate. (AVMA Journals)

This demonstrates that leukotoxin-related cross-protection is biologically plausible.

It does not prove that:

• Every Mannheimia-containing vaccine protects against B. trehalosi

• Every B. trehalosi strain is covered

• Every product is labelled for this organism

• Vaccination prevents all outbreaks

• Vaccination replaces colostrum, ventilation or early diagnosis

Use this evidence to inform a wider herd BRD vaccination programme, not as a universal product guarantee.

How Can Herd Risk Be Reduced?

Strengthen the Full BRD Programme

Review vaccination and control for the respiratory pathogens relevant to the property and region.

Vaccination should be timed so immunity has time to develop before predictable risk periods such as:

• Weaning

• Transport

• Mixing

• Sale-yard exposure

• Feedlot induction

• Major weather changes

Improve Colostrum Management

For calves, review:

• Colostrum quality

• Volume

• Timing

• Cleanliness

• Storage

• Feeding equipment

• Passive-transfer testing

Neonatal septicaemia should always trigger a close look at colostrum and hygiene, even when the isolated organism is unusual.

Improve Ventilation

Assess air quality at calf or cattle level, not only at human head height.

Look for:

• High humidity

• Condensation

• Ammonia

• Damp bedding

• Dead-air zones

• Excess stocking density

• Shared air between age groups

• Inadequate inlet or outlet area

Reduce Stress and Mixing

Where practical:

• Avoid unnecessary regrouping.

• Reduce transport stress.

• Separate major procedures in time.

• Avoid abrupt feed changes.

• Maintain reliable feed and water access.

• Quarantine incoming cattle.

• Avoid overcrowding.

Use Strong Biosecurity

General mixed-species biosecurity is sensible, particularly when sheep or goats are experiencing respiratory or septicaemic disease.

However, direct sheep-to-cattle transmission has not been established as the primary explanation for most bovine cases. Simply separating species will not compensate for poor ventilation, inadequate colostrum or uncontrolled viral BRD.

Use separate or properly disinfected:

• Feeding equipment

• Drenching equipment

• Stomach tubes

• Needles

• Waterers

• Treatment tools

• Transport pens

Monitor Outcomes

Track:

• Incidence

• Mortality

• Case-fatality rate

• Retreatment

• Relapse

• Time to recovery

• Weight loss

• Lung lesions

• Culture results

• Susceptibility

• Residue compliance

A treatment programme should be judged by whether disease and lung injury are declining, not by how many doses have been administered.

What Is the Prognosis?

The prognosis ranges from favourable in early responsive cases to grave in peracute septicaemia.

More Favourable Features

The outlook is better when:

• Disease is detected before recumbency.

• The animal remains able to eat and drink.

• Respiratory effort is moderate.

• The isolate is susceptible to a practical authorised treatment.

• Concurrent disease is identified.

• Environmental problems are corrected.

• New-case numbers begin falling.

More Guarded Features

Concern increases with:

• Sudden death as the first recognised sign

• Severe pleuropneumonia

• Septicaemia

• Polyarthritis

• Recumbency

• Neonatal weakness

• Failure of passive transfer

• Multidrug resistance

• Repeated previous treatment

• Ongoing rapid case accumulation

• Severe concurrent viral disease

The New Zealand outbreak shows how widely outcomes can differ. Eleven of the first 15 clinically affected neonatal calves died or were euthanased, while four calves that became ill later recovered following early antimicrobial treatment and herd intervention. That result belongs to one outbreak and is not a universal treatment success rate. (PubMed)

Common Mistakes

Calling It a New Global Cattle Epidemic

Current evidence supports an uncommon bovine pathogen capable of severe outbreaks, not a proven worldwide bovine surge.

Diagnosing It From One Nasal Swab

Upper-airway recovery is not equivalent to recovery from active lung lesions or a normally sterile site.

Assuming Every Isolate Is Highly Virulent

The pathogenicity study demonstrated that field-derived leukotoxin-positive and leukotoxin-negative isolates did not necessarily produce disease experimentally. (SpringerLink)

Assuming Leukotoxin PCR Proves Causation

A virulence gene increases biological plausibility. It does not replace pathology or epidemiology.

Claiming Only Cephalosporins Work

Susceptibility varies, and resistance to multiple antimicrobial classes has been documented.

Beginning Automatic Ceftiofur Metaphylaxis

Group treatment must be epidemiologically justified, veterinarian-directed, lawful and residue-compliant.

Assuming One Vaccine Guarantees Protection

One controlled vaccine study demonstrated cross-protection. That evidence cannot be transferred automatically to every product.

Ignoring the Primary BRD Drivers

Viral disease, ventilation, colostrum failure, stocking density and stress may matter more than the novelty of the bacterial name.

Waiting for Another Death Before Sampling

The freshest untreated carcass may provide the best diagnostic opportunity.

Frequently Asked Questions

Is Bibersteinia trehalosi new in cattle?

No. It has been associated with bovine disease for many years. It is uncommon compared with the major BRD bacteria but can cause severe pneumonia and septicaemia.

Can it cause sudden death?

Yes. Sudden death after little or no recognised illness has been documented in calves and older cattle. (Korea Science)

Does a positive culture prove that it caused the pneumonia?

No. The sample site, bacterial quantity, lesions, concurrent pathogens and herd pattern must all support causation.

Which antibiotic treats it?

There is no universal drug choice. Treatment should be based on the urgency of the outbreak, current labels, regional law, susceptibility testing and the veterinarian’s assessment.

Will a Mannheimia vaccine protect cattle?

A specific M. haemolytica toxoid-containing vaccine reduced disease in one controlled B. trehalosi challenge study. This does not guarantee protection from every product or field strain. (AVMA Journals)

Do sheep or goats commonly transmit it directly to cattle?

The bacterium occurs in several ruminant species, but routine direct small-ruminant-to-cattle transmission has not been established as the main cause of bovine outbreaks. Sensible mixed-species biosecurity remains appropriate.

Final Thoughts

Bibersteinia trehalosi deserves attention without exaggeration.

The most important points are:

1. It is a recognised but uncommon bovine pathogen.

2. It can cause rapidly fatal pneumonia and septicaemia.

3. Calves and adult cattle may be affected.

4. Sudden death may occur before obvious respiratory signs are noticed.

5. Some isolates may act primarily as secondary or opportunistic pathogens.

6. A positive upper-airway culture does not establish causation.

7. Fresh necropsy material and lesion-associated sampling are central to diagnosis.

8. MALDI-TOF, sequencing and PCR can improve bacterial identification.

9. Virulence-gene detection does not replace clinical interpretation.

10. Antimicrobial susceptibility varies between isolates.

11. Cephalosporins are not the only potentially active drug class.

12. Food-animal labels, restrictions and withdrawal periods must be followed.

13. One controlled study demonstrated possible vaccine cross-protection.

14. Colostrum, ventilation, hygiene, stress reduction and viral control remain essential.

15. Multiple sudden deaths or rapidly increasing respiratory disease requires immediate on-farm veterinary intervention.

The biggest mistake is allowing an unusual bacterial result to replace outbreak medicine. Confirm the pathology, collect the right samples, investigate every contributing pathogen, test susceptibility and correct the management conditions that allowed severe disease to develop.

---

ASK A VET™ can help organise herd records, respiratory scores, necropsy photographs, laboratory results, treatment responses and withdrawal reminders while producers work directly with their attending livestock veterinarian. A herd experiencing multiple sudden deaths, severe respiratory distress or rapidly rising mortality still requires immediate on-farm veterinary investigation.